- 66Reports naming them
- 1Categories
- 33Regions & countries
- See reportsGrowth in full reports
Where they show up
Geographies
- Africa 2
- APAC 2
Australia 2
Brazil 2
Canada 2
China 2
Ecuador 2
Egypt 2- Europe 2
France 2
Germany 2- Global 2
Hong Kong 2
India 2
Italy 2
Japan 2
Kenya 2- Latin America 2
Malaysia 2
Mexico 2- Middle East 2
New Zealand 2- North America 2
Philippines 2
Russia 2
Saudi Arabia 2
Singapore 2
South Africa 2
Spain 2
Thailand 2
UAE 2
UK 2
US 2
Alnylam Pharmaceuticals's markets
| Market | Category | World size | Growth |
|---|---|---|---|
| Amyloidosis Treatment | Pharmaceuticals | In full report | In full report |
| RNA Interference Therapeutics | Pharmaceuticals | In full report | In full report |
Companies they compete with most
Named as key players in the same markets as Alnylam Pharmaceuticals (number of shared markets).
Ionis Pharmaceuticals2 shared markets
Arrowhead Pharmaceuticals1 shared market
AstraZeneca1 shared market
BridgeBio Pharma1 shared market
Dicerna (Novo Nordisk)1 shared market
Novartis AG1 shared market
Pfizer Inc.1 shared market
AstraZeneca1 shared market
BridgeBio Pharma1 shared market
Dicerna (Novo Nordisk)1 shared market
Novartis AG1 shared market
Pfizer Inc.1 shared market
Recent reports naming Alnylam Pharmaceuticals
- Pharmaceuticals South Africa RNA Interference Therapeutics Market Analysis
- Pharmaceuticals US RNA Interference Therapeutics Market Analysis
- Pharmaceuticals Thailand RNA Interference Therapeutics Market Analysis
- Pharmaceuticals Singapore RNA Interference Therapeutics Market Analysis
- Pharmaceuticals Saudi Arabia RNA Interference Therapeutics Market Analysis
- Pharmaceuticals Russia RNA Interference Therapeutics Market Analysis
- Pharmaceuticals Philippines RNA Interference Therapeutics Market Analysis
- Pharmaceuticals New Zealand RNA Interference Therapeutics Market Analysis
Search all reports for Alnylam Pharmaceuticals All companies